Biotech · Public company · Westlake Village, CA, US
GENELUX Corp
Ticker GNLX · SEC CIK 0001231457
Track this companyFree. Adds GENELUX Corp to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline12
- Bevacizumab (or biosimilar)Phase 3 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Non-platinum chemotherapy: Physician's Choice of gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicinPhase 3 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- olvimulogene nanivacirepvecPhase 3 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Platinum chemotherapy: carboplatin (preferred) or cisplatinPhase 3 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 2 · Advanced Non-squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Non-platinum chemotherapy: paclitaxel or nab-paclitaxel for squamous cell NSCLC or pemetrexed for nonsquamous cell NSCLCPhase 2 · Advanced Non-squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Olvi-VecPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Olvimulogene nanivacirepvecPhase 2 · Advanced Non-squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Physician's Choice of Immune Checkpoint Inhibitor: pembrolizumab, nivolumab, cemiplimab, atezolizumab, durvalumabPhase 2 · Advanced Non-squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Platinum chemotherapy: carboplatin or cisplatinPhase 2 · Advanced Non-squamous Non-small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Platinum-doublet with or without bevacizumabPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- GL-ONC1Advanced Stage Cancer (Solid Tumor Disease for 4 Patients)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL CancerPHASE2 · RECRUITING · started Sep 26, 2024ClinicalTrials.gov NCT06463665 · fetched Nov 12, 2026
- Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)PHASE3 · RECRUITING · started Aug 31, 2022ClinicalTrials.gov NCT05281471 · fetched Nov 12, 2026
- Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerPHASE1_PHASE2 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02759588 · fetched Nov 12, 2026
- GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersPHASE1 · TERMINATED · started Mar 25, 2016ClinicalTrials.gov NCT02714374 · fetched Nov 12, 2026
- Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and MesotheliomaPHASE1 · COMPLETED · started Jan 1, 2013ClinicalTrials.gov NCT01766739 · fetched Nov 12, 2026
- Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of CareNO_LONGER_AVAILABLEClinicalTrials.gov NCT03420430 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 2, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 5, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 3, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 7, 2025 · fetched Nov 12, 2026